P/B
15
ChronoScale
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
$2.7B
Market Cap • 10/9/2026
2012
(14 years)
Founded
2013
(13 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
37,8
P/EBITDA
118,5
P/OCF
69,3
P/FCF
222,1
P/E
—
BVPS
1,2
EPS
—
Market Cap
Market Cap
2,7B
EV
2,8B
EV/Revenue
39,4
EV/EBITDA
123,5
EV/EBIT
-75,2
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-0,7%
Total Yield
-0,7%
Payout
0%
Retained Earnings
-199,5M
Profitability
Gross Margin
—
EBITDA Margin
31,9%
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
0%
Capex/Revenue
37,5%
Capex/D&A
44,5%
Capex/OCF
68,8%
SBC/OCF
3,3%
% PPE
69,5%
% Goodwill
16,7%
ROE
—
ROIC
—
Leverage
N.D./EBITDA
4,9
Debt/Equity
0%
Current Ratio
0,5
Quick Ratio
0,3
Interest Coverage
391,3%
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!